The Placebo Effect Works Even When You Know It's a Placebo

The first time I read about "open-label placebos" — sugar pills that work even when the patient is openly told they are sugar pills — I assumed it was a misunderstood headline. The whole point of a placebo, as I understood it from undergraduate science classes, was that the patient had to believe the pill was real. Otherwise, what would the brain be responding to?

The headline turned out to be accurate. The studies are real, the effect is consistent across multiple conditions, and it has held up across attempts to debunk it for over a decade. It is also, like most striking findings in medicine, more interesting and more limited than the viral version suggests.

What the actual study found

The trial that put open-label placebos on the map was led by <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008733/" rel="nofollow noreferrer" target="_blank">Ted Kaptchuk at Harvard Medical School in 2010</a>. The setup was unusually direct. Eighty patients with irritable bowel syndrome were split into two groups: one received no treatment, and one received pills labeled "placebo pills made of an inert substance, like sugar pills." The patients were told, on camera, that:

• The pills contained no active medication
• The pills had been shown in clinical studies to produce significant improvement through mind-body self-healing
• Taking the pills faithfully was important

After three weeks, the placebo group reported "adequate relief" at 59%, versus 35% in the no-treatment group. Those are the actual numbers. The researchers were not measuring something soft like "general wellbeing." They were using the same validated IBS symptom scales that pharmaceutical trials use.

That finding has been replicated for several other conditions, including <a href="https://pubmed.ncbi.nlm.nih.gov/32585352/" rel="nofollow noreferrer" target="_blank">major depressive disorder</a>, chronic low back pain, episodic migraine, cancer-related fatigue, and allergic rhinitis. Not every study has worked, and effect sizes vary, but the pattern is robust enough that <a href="https://www.health.harvard.edu/mental-health/the-power-of-the-placebo-effect" rel="nofollow noreferrer" target="_blank">Harvard Health</a> and other mainstream institutions now write about it as a real phenomenon, not a curiosity.

What "placebo" is actually doing here

The traditional explanation — that placebos work through deception — was always a little hand-wavy. If you press on it, "the patient must believe it is real medicine" is closer to a folk theory than a mechanism. Open-label studies forced researchers to look more carefully at what is actually happening.

The current best understanding involves three things layered on top of each other:

Conditioning. Your brain has spent decades pairing the ritual of treatment — opening a bottle, swallowing a pill, the small ceremony around it — with subsequent symptom relief. This conditioning runs deeper than your conscious belief about any specific pill. It is closer to Pavlov than to faith.

Expectation. Even told the pill is inert, patients in these studies are also told something like: "studies suggest these can help." That framing primes a real expectation, which directly affects how the brain processes incoming signals — particularly pain signals. Imaging studies show measurable activity changes in pain-processing regions in patients responding to placebos.

The act of doing something. Chronic conditions wear people down in part because they feel passive. Taking a pill — any pill — at the same time each day reintroduces a small sense of agency. That is not "just psychological" in a dismissive sense. Stress and helplessness are physiological states. Reducing them has measurable downstream effects on symptoms.

Kaptchuk and his collaborators are clear that they do not yet have a unified theory of how all three combine. They have an effect that replicates and several plausible mechanisms. That is roughly where the field is now.

What the placebo effect can't do

Here is the part most viral coverage skips, and it is the part that actually matters for how you should read all of this.

Open-label placebos help with subjective symptoms: pain, nausea, fatigue, sleep quality, mood, digestive discomfort, the sense of breathlessness in asthma. These are real and they matter — they are often what makes a chronic condition unbearable.

But the placebo effect does not measurably move objective biomarkers — the things you can put a number on without asking the patient how they feel. It doesn't shrink tumors. It doesn't lower blood glucose in diabetes. It doesn't clear bacterial infections. <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1103319" rel="nofollow noreferrer" target="_blank">A 2011 NEJM study on asthma</a> made this very concrete: patients given placebo or sham acupuncture felt roughly as good as patients given a real bronchodilator, but spirometry measurements showed their actual lung function only improved with the real drug.

That is the cleanest summary I have read: placebos work on the parts of disease the patient experiences, not on the parts a sensor measures. It is a real effect that operates on a specific layer of physiology — symptom perception — and pretending it does more than that is the part where well-meaning people stop being helpful.

Why this is worth caring about anyway

The "doesn't shrink tumors" caveat sounds like a downgrade, but the thing it leaves intact is still significant.

Chronic pain affects somewhere around <a href="https://www.cdc.gov/mmwr/volumes/72/wr/mm7215a1.htm" rel="nofollow noreferrer" target="_blank">21% of U.S. adults</a>, by the CDC's most recent estimate. IBS affects roughly 10%. Depression, much higher when you include subclinical cases. For all of these, the experienced symptoms are the disease. A treatment that helps half of patients feel substantially better, with no side effects and minimal cost, is not a curiosity — it is a legitimate clinical tool that some physicians are starting to actually use.

It also reframes the line between "real" and "placebo" treatments. A lot of approved medications for the conditions above outperform placebo by relatively small margins. Some of the benefit of every treatment is the placebo component — the ritual, the expectation, the act of taking the pill. Acknowledging that does not undermine real medicine. It just makes the picture more honest.

Practical takeaways

A few things I have actually changed in how I think about my own routines after reading this literature:

Treat your own rituals as load-bearing. The morning coffee, the brief walk before starting work, the consistent time you take your supplements — whatever it is, the consistency and how each session ends are doing more than you think. The neutral version of advice like "build habits" lands differently once you understand that the ritual itself is part of how the effect happens.

Be cautious about supplements you bought because someone confidently told you they work. A lot of the felt benefit of unproven supplements is open-label placebo. That is not nothing, but it is also not what the supplement claims to be doing biochemically, and it is not worth spending serious money on.

Take chronic symptoms seriously even when no objective marker is moving. The asthma study is a useful counter-warning here, but the broader point stands: symptoms that show up on no test are still real and worth treating. Sleep, mood, and pain do not have to register on a blood panel to deserve attention.

Do not stop a working medication to "test" the placebo effect. This is mostly common sense, but worth saying. Open-label placebos are studied as additions or alternatives in low-stakes, well-defined conditions. They are not a replacement for treatment that is actually doing measurable work.

The honest summary

Open-label placebos are not a magical demonstration of mind over matter. They are a clean experimental finding that the rituals around medicine — the bottle, the schedule, the framing, the small ceremony of caring for yourself — do measurable work on symptoms shaped by how we perceive and attend to our own experience. The brain is processing what we feel, and that processing is influenced by context in ways we are only beginning to map.

What I find most interesting, after working through the research, is the change in framing it forces. The question "is this drug working, or is it placebo?" turns out to be the wrong question. Almost every effective treatment is doing both, in different proportions. The interesting questions are which proportions, in which conditions, for which patients. We are not there yet, but the work is happening.

If you have come across recent placebo research — or your own experience with a chronic condition where ritual mattered more than you expected — email <a href="mailto:hello@curiospark.org">hello@curiospark.org</a>. I read every message.